Effekten af Mirapexin er blevet evalueret i fire placebo kontrollerede kliniske forsøg hos cirka 1000 patienter med moderat til meget svær idiopatisk Restless Legs Syndrom.
The efficacy of MIRAPEXIN was evaluated in four placebo-controlled clinical trials in approximately 1000 patients with moderate to very severe idiopathic Restless Legs Syndrome.